Venlafaxine.
Ereshefsky
L
L
D018687:Antidepressive Agents, Second-Generation / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D003511:Cyclohexanols / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006801:Humans; D006899:Mixed Function Oxygenases / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D019389:Cytochrome P-450 CYP2D6; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride; C104464:CYP3A protein, human